Observational Study - ILM Peeling

July 30, 2014 updated by: M. Dominik Fischer, University Hospital Tuebingen

Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling

This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • BW
      • Tuebingen, BW, Germany, 72076
        • Centre for Ophthalmology, University Hospital Tuebingen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Inpatients at the University Eye Hospital Tuebingen

Description

Inclusion Criteria:

  • Clinical diagnosis of Epimacular Gliosis
  • Must be scheduled for ILM-peeling independently of study
  • Must be older then 18 years of age

Exclusion Criteria:

  • Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
  • Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Epimacular Gliosis Without Macular Hole
Epimacular Gliosis With Macular Hole

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
BCVA
Time Frame: 6 months after ILM peeling
6 months after ILM peeling

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital Tuebingen

Investigators

  • Principal Investigator: Florian Gekeler, MD, Centre for Ophthalmology, University Hospital Tuebingen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2010

Primary Completion (ACTUAL)

July 1, 2014

Study Completion (ACTUAL)

July 1, 2014

Study Registration Dates

First Submitted

March 8, 2010

First Submitted That Met QC Criteria

March 8, 2010

First Posted (ESTIMATE)

March 9, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

July 31, 2014

Last Update Submitted That Met QC Criteria

July 30, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ILM Peeling

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Macular Hole

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe